Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of Ambulation Training Utilizing an Exoskeleton Robot on Subjects With Spinal Cord Injury

5. januar 2018 oppdatert av: Nai-Hsin Meng, China Medical University Hospital

Evaluation of the Physiological and Psychological Effects of Ambulation Training Utilizing an Exoskeleton Robot on Subjects With Spinal Cord Injury

The present study aims to investigate the effects of ReWalk exoskeleton robot training on various physiological and psychological parameters among subjects with spinal cord injury, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life. Ten patients with paraplegia caused by spinal cord injury will be recruited from the out-patient clinic of Department of Physical Medicine and Rehabilitation at the China Medical University hospital. All participants will undergo dual X-ray absorptiometry to evaluate the baseline bone mineral density. Eligible participants will then take ReWalk training sessions comprises of 3 x 1-hour sessions per week for 40 sessions. A comprehensive battery of outcome measures, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life, will be utilized for comparison after 40 sessions of ReWalk ambulation training.

Studieoversikt

Detaljert beskrivelse

The loss of upright mobility has a profound effect on the health and quality of life for individuals with a spinal cord injury (SCI). The ReWalk exoskeleton is an FDA-cleared, wearable, computer-controlled exoskeleton robot that enables subjects with SCI to stand and walk using crutches to keep balance. China Medical University Hospital is the second hospital in Taiwan to acquire this relatively new rehabilitation robot. ReWalk exoskeleton not only helps the patients with paraplegia regain their ability to walk, previous studies also suggest that restoration of upright mobility may help mitigate the physical and psychological decline routinely experienced by individuals with SCI.

The present study aims to investigate the effects of ReWalk exoskeleton robot training on various physiological and psychological parameters among subjects with spinal cord injury, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life. Ten patients with paraplegia caused by spinal cord injury will be recruited from the out-patient clinic of Department of Physical Medicine and Rehabilitation at the China Medical University hospital. All participants will undergo dual X-ray absorptiometry to evaluate the baseline bone mineral density. Eligible participants will then take ReWalk training sessions comprises of 3 x 1-hour sessions per week for 40 sessions. The first 20 or so hours of training sessions focus on basic ReWalk skills, and the following training sessions focus on advanced ReWalk skills. A comprehensive battery of outcome measures, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life, will be utilized to obtain an in-depth overview and comparison of the treatment efficacy after 40 sessions of ReWalk ambulation training. The measures include: muscle strength measurements, Berg Balance Scale, modified Functional Reach Test, 10-Meters Walking Test, Timed Up and Go test, the Short Form-36 and Spinal Cord Injury-Quality Of Life questionnaires for health-related quality of life measurement. Dual X-ray absorptiometry will be used to measure the bone mineral density of the lumbar spine, the proximal femoral region and the distal forearms. It will also be used to estimate fat mass and lean body mass of the participants. All the outcome assessments, except for the Timed Up and Go and the 10-Metersr Walking Test, will be performed prior to the first training session and again at the end of the ReWalk ambulation training sessions. Descriptive data will be provided for all demographic parameters and with a mix-design ANOVA analysis employed to compare pre- and post-training conditions for all repeated outcome measures.

Studietype

Intervensjonell

Registrering (Forventet)

10

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Taichung City, Taiwan, 404
        • Rekruttering
        • China Medical University Hospial
        • Hovedetterforsker:
          • Nai-Hsin Meng, M.D.
        • Ta kontakt med:
        • Underetterforsker:
          • Li-Wei Chou, M.D. Ph.D.
        • Underetterforsker:
          • Pei-Yu Yang, M.D.

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

20 år til 65 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. Between the age of 20-65 years old;
  2. Have paraplegia resulting from thoracic or lumbar spinal cord injury.
  3. At least 6 months after onset of the spinal cord injury
  4. Well motivated and willing to participate 40 hours of ReWalk ambulation training sessions.

Exclusion Criteria:

  1. Have spinal cord injury neurologic level above T4
  2. Height greater than 190 cm or lower than160 cm
  3. Weight greater than 100 kg
  4. Have osteoporosis (T-score < -2.5)
  5. Deep vein thrombosis
  6. Severe orthostatic hypotension precluding standing and walking training
  7. Pregnancy
  8. Cognitive impairments that would impact on the safe participation in the study
  9. Severe spasticity of lower limbs (Modified Ashworth Scale >3)
  10. Contracture of the ankle, or a knee flexion contracture greater than 10 degrees
  11. Musculoskeletal conditions that affected gait capacity
  12. Co-existence of other neurological diseases

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Exoskeleton robot ambulation training
Ambulation training utilizing an exoskeleton robot
Participants undergo 40 hours of ambulation training utilizing an exosksleton robot within 3 months.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
bone mineral density
Tidsramme: Change from baseline at 1 week after completion of 40 hours of ambulation training
bone mineral density of the lumbar spine, the proximal femoral region and the distal forearms, measured by dual X-ray absorptiometry
Change from baseline at 1 week after completion of 40 hours of ambulation training

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
SF-36
Tidsramme: change from baseline at 1 week after completion of 40 hours of ambulation training
SF-36 contains 36 items comprising eight subscales: physical functioning (PF), role limitations due to physical problems (RP), bodily pain, general health perceptions (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH). All subscales are transformed into a 0-100 scale, with 100 indicating the best status.
change from baseline at 1 week after completion of 40 hours of ambulation training
Spinal Cord Injury-Quality of Life measurement system
Tidsramme: change from baseline at 1 week after completion of 40 hours of ambulation training

The SCI-QOL consists of 19 item banks, including the SCI-Functional Index banks, and 3 fixed-length scales measuring physical, emotional, and social aspects of health-related QOL (HRQOL). A description of the score range (and which values are considered to be a better or worse outcome) is not included because it greatly exceeds the 999-character limitation allowed in the box of "descrpition"

Emotional Health Domain:

Positive Affect & Well-Being, Depression, Anxiety, Stigma, Resilience, Grief/Loss, Self-Esteem and Psychological Trauma

Physical-Medical Health Domain:

Skin/Pressure Ulcers Scale, Bladder Complications Scale, Bladder Management Difficulties, Bowel Management Difficulties, Pain Interference and Pain Behavior Scale.

Social Participation Domain:

Ability to Participate in Social Roles and Activities, Satisfaction with Social Roles and Activities, Independence.

SCI-Functional Index banks: Basic Mobility, Ambulation, Fine Motor, Self-Care and Wheelchair activities.

change from baseline at 1 week after completion of 40 hours of ambulation training
fat mass
Tidsramme: change from baseline at 1 week after completion of ambulation training
fat mass measured by dual X-ray absorptiometry
change from baseline at 1 week after completion of ambulation training
lean body mass
Tidsramme: change from baseline at 1 week after completion of 40 hours of ambulation training
lean body mass measured by dual X-ray absorptiometry
change from baseline at 1 week after completion of 40 hours of ambulation training
Berg Balance Scale
Tidsramme: change from baseline at 1 week after completion of 40 hours of ambulation training
measuring sitting balance ability; minimum score: 0, maximu score 56; higher values represent a better outcome
change from baseline at 1 week after completion of 40 hours of ambulation training

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Nai-Hsin Meng, M.D., China Medical University, China Medical University Hospital

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

23. november 2017

Primær fullføring (Forventet)

31. oktober 2019

Studiet fullført (Forventet)

31. desember 2019

Datoer for studieregistrering

Først innsendt

7. november 2017

Først innsendt som oppfylte QC-kriteriene

8. november 2017

Først lagt ut (Faktiske)

14. november 2017

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

8. januar 2018

Siste oppdatering sendt inn som oppfylte QC-kriteriene

5. januar 2018

Sist bekreftet

1. januar 2018

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Ja

produkt produsert i og eksportert fra USA

Ja

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Ryggmargsskader

3
Abonnere